Evaluation of the Membrane Permeability (PAMPA and Skin) of Benzimidazoles with Potential Cannabinoid Activity and their Relation with the Biopharmaceutics Classification System (BCS)

The permeability of five benzimidazole derivates with potential cannabinoid activity was determined in two models of membranes, parallel artificial membrane permeability assay (PAMPA) and skin, in order to study the relationship of the physicochemical properties of the molecules and characteristics...

Full description

Saved in:
Bibliographic Details
Published inAAPS PharmSciTech Vol. 12; no. 2; pp. 573 - 578
Main Authors Alvarez-Figueroa, M. Javiera, Pessoa-Mahana, C. David, Palavecino-González, M. Elisa, Mella-Raipán, Jaime, Espinosa-Bustos, Cristián, Lagos-Muñoz, Manuel E.
Format Journal Article
LanguageEnglish
Published Boston Springer US 01.06.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The permeability of five benzimidazole derivates with potential cannabinoid activity was determined in two models of membranes, parallel artificial membrane permeability assay (PAMPA) and skin, in order to study the relationship of the physicochemical properties of the molecules and characteristics of the membranes with the permeability defined by the Biopharmaceutics Classification System. It was established that the PAMPA intestinal absorption method is a good predictor for classifying these molecules as very permeable, independent of their thermodynamic solubility, if and only if these have a Log P oct value <3.0. In contrast, transdermal permeability is conditioned on the solubility of the molecule so that it can only serve as a model for classifying the permeability of molecules that possess high solubility (class I: high solubility, high permeability; class III: high solubility, low permeability).
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1530-9932
1530-9932
DOI:10.1208/s12249-011-9622-1